skip to main content
select
select
select
DateCaseTitleExpertiseCounsel
May 5, 2020 2020 FC 593 Janssen Inc. et al v Teva Canada Limited We successfully represented Janssen in this patent infringement action under the new PMNOC Regulations concerning Janssen’s Invega Sustenna (...

Patents

Jul 13, 2018 2018 FC 736 Eli Lilly Canada Inc. et al v. Apotex Inc. We represented Eli Lilly, Daiichi and Ube in this application relating to a patent covering Eli Lilly’s EFFIENT product.

Patents

Apr 10, 2018 Federal Court File Nos. T-598-17 through T-605-17 AbbVie Corporation et al v Samsung Bioepis Co. Ltd. We represented AbbVie in a series of eight applications under the PMNOC Regulations relating to AbbVie’s blockbuster drug HUMIRA.  The c...

Patents

Apr 9, 2018 Federal Court File No. T-1355-17 Samsung Bioepis Co., Ltd. v AbbVie Biotechnology Ltd. et al. We represented AbbVie in a patent impeachment action brought by Samsung Bioepis in relation to Samsung Bioepis’ biosimilar to AbbVIe’s ...

Patents

Dec 9, 2016 2016 FC 1361 Janssen Inc. et al. v. Actavis Pharma Company et al. We successfully represented Janssen in a patent case relating to the ADHD medication CONCERTA.  The generic company Actavis Pharma had challen...

Patents

May 31, 2016 2016 FC 593 Janssen Inc. v. Teva Canada Limited We successfully represented Janssen in this action for damages resulting from infringement of the patent covering Janssen’s LEVAQUIN product....

Patents

Sep 16, 2015 2015 FCA 192 Actavis Pharma Company v. Alcon Canada Inc. We successfully represented Alcon and Bayer in this appeal brought by Actavis. The Federal Court had upheld the validity of Bayer’s patent re...

Patents

Aug 31, 2015 Court File No. T-2247-14 Sanofi-Aventis Canada Inc. v. Eli Lilly Canada Inc. We successfully represented Eli Lilly in a patent proceeding relating to Eli Lilly’s diabetes medicine BASAGLAR. After filing a motion to dis...

Patents

Oct 28, 2014 2014 FCA 242 Janssen Inc. v. Abbvie Corporation We successfully represented Janssen on this appeal from a refusal to grant an amendment to Janssen’s pleading.  The Court of Appeal agre...

Patents

May 14, 2014 2014 FC 462 Alcon Canada Inc. v. Cobalt Pharmaceuticals Company We successfully defended the validity of Bayer’s patent covering the antibiotic moxifloxacin (AVELOX® and VIGAMOX ®) and obtaine...

Patents

Apr 11, 2012 2012 FC 410 Alcon Canada Inc. v. Apotex Inc. We represented Alcon in a proceeding under the PMNOC Regulations relating to PATANOL.  

Patents

May 12, 2010 2010 FC 42 Janssen-Ortho Inc. v. Canada (Health) We represented Janssen-Ortho and Alza Corporation in a proceeding under the PMNOC Regulations relating to CONCERTA®.

Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy